羊瘙羊因子263K毒株感染金黄地鼠后鼠脑组织中检出PrP—res蛋白及其神经病理学研究

羊瘙痒病是累及山羊及绵羊的传播海绵状脑病。为了观察羊瘙痒因子（Scrapie）的病原特征及病理组织改变特点,将羊瘙痒因子263K毒株颅内接种至金黄地鼠。经过81－110天的潜伏期,89％的动物发病（17／19只）。对发病地鼠的神经病理学检测发现海绵状空泡变性的检出率为59％,淀粉斑的检出率为17.6％,利用免疫组化和蛋白酶消化后Western blotting检测证实,100％的发病地鼠的脑组织中都出现蛋白酶抗性朊蛋白（PrP-res）。17只发病地鼠脑组织提取物中,PrP-res的泳动位置和分子量大小完全一致,出现两条分子量在25kD-31kD的反应带。尝试应用快速玻片印迹法检测病变组织中的PrP-res,结果显示,与常规因定包埋切片的免疫组化检出效果相似。这提示脑组织印片法可成为临床检测克－雅氏病（Creutzfeldt-Jacob disease,CJD)患者脑组织活检标本中PrP-res的快速、有效的方法,羊瘙痒因子263K成功感染金黄地鼠再次证明,金黄地鼠是TSE感染因子良好的动物模型,发病率高,潜伏期短,发病动物PrP-res的检出率明显高于典型病理改变的检出率,新生成的PrP-res的电泳类型与接种的TSE因子有关,与宿主的个体差异无关,提示TSE感染因子的确存在“株”的现象。     

羊瘙痒因子263K毒株感染金黄地鼠后鼠脑组织中检出PrP-res蛋白及其神经病理学研究

羊瘙痒病是累及山羊及绵羊的可传播海绵状脑病。为了观察羊瘙痒因子 (Scrapie)的病原特征及病理组织改变特点 ,将羊瘙痒因子 2 6 3K毒株颅内接种至金黄地鼠。经过 81～ 110天的潜伏期 ,89%的动物发病 (17/19只 )。对发病地鼠的神经病理学检测发现 ,海绵状空泡变性的检出率为 5 9% ,淀粉样斑的检出率为 17 6 %。利用免疫组化和蛋白酶消化后的Westernblotting检测证实 ,10 0 %的发病地鼠的脑组织中都出现蛋白酶抗性朊蛋白 (PrP res)。17只发病地鼠脑组织提取物中 ,PrP res的泳动位置和分子量大小完全一致 ,出现两条分子量在 2 5kD～ 31kD的反应带。尝试应用快速玻片印迹法检测病变组织中的PrP res,结果显示 ,与常规固定包埋切片的免疫组化检出效果相似。这提示脑组织印片法可成为临床检测克 雅氏病 (Creutzfeldt Jacobdisease ,CJD)患者脑组织活检标本中PrP res的快速、有效的方法。羊瘙痒因子 2 6 3K成功感染金黄地鼠再次证明 ,金黄地鼠是TSE感染因子良好的动物模型 ,发病率高 ,潜伏期短 ,发病动物PrP res的检出率明显高于典型病理改变的检出率。新生成的PrP res的电泳类型与接种的TSE因子有关 ,与宿主的个体差异无关 ,提示TSE感染因子的确存在“株”的现象。     

羊瘙痒病小鼠适应株139A可突破种属屏障颅内感染金黄地鼠

羊瘙痒病感染因子可以根据疾病发生的潜伏期、临床病程、神经病理学特征以及PrPSc分子特征等分为不同的毒株,目前已经证实有20余种.在可传播性海绵状脑病的发病过程中存在着明显的种属屏障作用.将小鼠适应株139A颅内接种至金黄地鼠,以观测感染因子对种属屏障的突破及感染特征.在接种385～405天后,感染动物出现明显症状,与以往报道的金黄地鼠适应株263K不同,139A毒株发病动物出现严重的瘙痒,而无明显的共济失调.感染动物自出现明显症状到死亡的时间明显长于263K毒株感染金黄地鼠.进一步脑组织电镜和Western blot检测证实,存在有羊瘙痒病相关纤维和PrP-res.这证明小鼠适应株139A可突破种属屏障感染金黄地鼠.经系统比较,139A和263K毒株在潜伏期、主要临床症状和临床病程显示出明显的差异,而PrP-res的泳动位置和糖基化比率差异不大,仅139A毒株的单糖基化分子位置似乎略高于263K.动态观测处于潜伏期的接种动物脑组织羊瘙痒病相关纤维和PrP-res,发现PrPSc的出现明显早于临床症状.     

Prion疾病和“protein only”假说

Prion病是指一类由蛋白质错误折叠导致的具有传染性的疾病.人类的纹状体脊髓变性病、库鲁病、脑软化病,和致死的家族性失眠症以及动物的羊瘙痒病和牛海绵状脑炎即疯牛病,都是致死性的神经退行性疾病,它们都属于传染性海绵状脑炎,统称Prion病.PrP^C是Prion蛋白在细胞内的正常形式,PrP^Sc是其致病形式.根据“protein only”假说,PrP^C向PrP^Sc的转化是致病的关键步骤.简要介绍了PrP蛋白的结构特征、PrP^C向PrP^Sc转化的可能机制、影响PrP^C向PrP^Sc转化的重要因素和PrP在细胞内的生物学过程等方面的研究进展,讨论了Prion疾病的诊断和治疗方法.     

朊病毒病

朊病毒是一类可传递的蛋白质感染颗粒,似乎仅仅由一种修饰后的蛋白ＰｒＰ＾ｓｃ构成。ＰｒＰ＾ｓｃ由政党细胞蛋白ＰｒＰ＾ｃ通过翻译后加工、发生构象变化而形成。牛海绵状脑病和人Ｃｒｅｕｔｚｆｅｌｄｔ－Ｊａｃｏｂ病（ＣＪＤ）是朊病毒引起的最名的中枢神经系统变性疾病。ＤＪＤ有散发性、家族性、传染性、医原性等,有语气表明牛朊病毒已传递至人类导致新的变异性ＣＪＤ。针对朊病毒独特的致病机制可得出若干防治策略。     

朊病毒播散机制的研究进展

传染性海绵状脑病(Transmissible spongiform encephalopathies,TSE)是一类致死性中枢神经系统的慢性退化性疾病,它包括了疯牛病(Mad cowdisease,MCD)即牛海绵状脑病(Bovine spongiformencephalopathy,BSE)、羊瘙痒病(Scrapie)、克雅病(Creutzfeldt-Jakob disease,CJD)、GSS综合征     

朊病毒播散机制的研究进展

传染性海绵状脑病(Transmissible spongiform encephalopathies,TSE)是一类致死性中枢神经系统的慢性退化性疾病,它包括了疯牛病(Mad cowdisease,MCD)即牛海绵状脑病(Bovine spongiformencephalopathy,BSE)、羊瘙痒病(Scrapie)、克雅病(Creutzfeldt-Jakob disease,CJD)、GSS综合征     

羊痒疫及其相关疾病病原体——朊病毒

阮病毒是羊痒疫及其相关疾病如人的库鲁病、疯牛病及牛海绵状脑组织疾病的脑原体。本文综述了朊病毒的理化性质、形态结构、组织分布、分离鉴定及其分子生物学研究的最新进展。     

微管相关蛋白tau与朊蛋白的相互作用

微管相关蛋白tau参与了许多神经退行性疾病的发生, 其中包括一些人类可传播性海绵状脑病. 为了探讨tau与朊蛋白(PrP)之间可能存在的关系, 首先通过GST pull-down和免疫共沉淀等技术发现重组tau蛋白可通过微管结合区与来源于正常叙利亚仓鼠脑组织中的正常细胞膜朊蛋白(PrP^C)和羊瘙痒因子263K感染仓鼠脑组织的异常朊蛋白(PrPSc)相结合. 利用免疫共沉淀实验发现在正常和羊瘙痒因子感染的仓鼠脑组织中存在tau蛋白与PrPC和PrPSc的相互作用, 并且利用激光共聚焦方法检测到PrP和tau蛋白在CHO细胞内具有共定位的关系. 为了确定PrP与tau蛋白相互作用的部位, 构建了不同区域的PrP片段, 从而证明PrP与tau蛋白相互作用的区域位于PrP的N端序列(23~91 aa). PrP与tau蛋白分子间相互作用的直接实验证据提示tau蛋白可能参与PrP的正常生理功能以及朊病毒病的病理过程.     

疯牛病研究进展

近年来,英国疯牛病成为国内外新闻媒体关注的焦点,它不仅给英国养牛业造成了巨大的经济损失,同时也引起了世界各国政府及农业主管部门的高度重视,疯牛病是对牛海绵状脑病（Bovine Spongiform Encephalopathy BSE)的俗称,它是一种慢性,具有传染性的致死性中枢神经系统疾病,该病临床和组织学病理学特征是病畜神经失常,共济失调,感觉过敏和中枢神经系统灰质空泡化,疯牛病被认为与朊病毒（Prion)有关,因此与克-雅氏病,羊痒病等一起被统称为朊病毒病,朊病毒病是由正常朊病毒蛋白（PrPC)发生蛋白折叠错误变成异常朊病毒蛋白（PrPSC)引起的,BSE主要发生于以英国为中心的欧洲各国家和地区,各国采取了一系列的措施,防制BSE危害人类健康,中国至今尚无疯牛病发生。     

Detection of Bovine Spongiform Encephalopathy-Specific PrPSc by Treatment with Heat and Guanidine Thiocyanate

The conversion of a ubiquitous cellular protein (PrP(C)), an isoform of the prion protein (PrP), to the pathology-associated isoform PrP(Sc) is one of the hallmarks of transmissible spongiform encephalopathies such as bovine spongiform encephalopathy (BSE). Accumulation of PrP(Sc) has been used to diagnose BSE. Here we describe a quantitative enzyme-linked immunosorbent assay (ELISA) that involves antibodies against epitopes within the protease-resistant core of the PrP molecule to measure the amount of PrP in brain tissues from animals with BSE and normal controls. In native tissue preparations, little difference was found between the two groups. However, following treatment of the tissue with heat and guanidine thiocyanate (Gh treatment), the ELISA discriminated BSE-specific PrP(Sc) from PrP(C) in bovine brain homogenates. PrP(Sc) was identified by Western blot, centrifugation, and protease digestion experiments. It was thought that folding or complexing of PrP(Sc) is most probably reversed by the Gh treatment, making hidden antigenic sites accessible. The digestion experiments also showed that protease-resistant PrP in BSE is more difficult to detect than that in hamster scrapie. While the concentration of PrP(C) in cattle is similar to that in hamsters, PrP(Sc) sparse in comparison. The detection of PrP(Sc) by a simple physicochemical treatment without the need for protease digestion, as described in this study, could be applied to develop a diagnostic assay to screen large numbers of samples.     

Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans

Cattle infected with bovine spongiform encephalopathy (BSE) appear to be a reservoir for transmission of variant Creutzfeldt-Jakob disease (vCJD) to humans. Although just over 100 people have developed clinical vCJD, millions have probably been exposed to the infectivity by consumption of BSE-infected beef. It is currently not known whether some of these individuals will develop disease themselves or act as asymptomatic carriers of infectivity which might infect others in the future. We have studied agent persistence and adaptation after cross-species infection using a model of mice inoculated with hamster scrapie strain 263K. Although mice inoculated with hamster scrapie do not develop clinical disease after inoculation with 10 million hamster infectious doses, hamster scrapie infectivity persists in brain and spleen for the life span of the mice. In the present study, we were surprised to find a 1-year period postinfection with hamster scrapie where there was no evidence for replication of infectivity in mouse brain. In contrast, this period of inactive persistence was followed by a period of active replication of infectivity as well as adaptation of new strains of agent capable of causing disease in mice. In most mice, neither the early persistent phase nor the later replicative phase could be detected by immunoblot assay for protease-resistant prion protein (PrP). If similar asymptomatic carriers of infection arise after exposure of humans or animals to BSE, this could markedly increase the danger of additional spread of BSE or vCJD infection by contaminated blood, surgical instruments, or meat. If such subclinical carriers were negative for protease-resistant PrP, similar to our mice, then the recently proposed screening of brain, tonsils, or other tissues of animals and humans by present methods such as immunoblotting or immunohistochemistry might be too insensitive to identify these individuals.     

Molecular analysis of the protease-resistant prion protein in scrapie and bovine spongiform encephalopathy transmitted to ovine transgenic and wild-type mice

The existence of different strains of infectious agents involved in scrapie, a transmissible spongiform encephalopathy (TSE) of sheep and goats, remains poorly explained. These strains can, however, be differentiated by characteristics of the disease in mice and also by the molecular features of the protease-resistant prion protein (PrP(res)) that accumulates into the infected tissues. For further analysis, we first transmitted the disease from brain samples of TSE-infected sheep to ovine transgenic [Tg(OvPrP4)] and to wild-type (C57BL/6) mice. We show that, as in sheep, molecular differences of PrP(res) detected by Western blotting can differentiate, in both ovine transgenic and wild-type mice, infection by the bovine spongiform encephalopathy (BSE) agent from most scrapie sources. Similarities of an experimental scrapie isolate (CH1641) with BSE were also likewise found following transmission in ovine transgenic mice. Secondly, we transmitted the disease to ovine transgenic mice by inoculation of brain samples of wild-type mice infected with different experimental scrapie strains (C506M3, 87V, 79A, and Chandler) or with BSE. Features of these strains in ovine transgenic mice were reminiscent of those previously described for wild-type mice, by both ratios and by molecular masses of the different PrP(res) glycoforms. Moreover, these studies revealed the diversity of scrapie strains and their differences with BSE according to labeling by a monoclonal antibody (P4). These data, in an experimental model expressing the prion protein of the host of natural scrapie, further suggest a genuine diversity of TSE infectious agents and emphasize its linkage to the molecular features of the abnormal prion protein.     

Molecular analysis of the abnormal prion protein during coinfection of mice by bovine spongiform encephalopathy and a scrapie agent

Molecular features of the proteinase K-resistant prion protein (PrP res) may discriminate among prion strains, and a specific signature could be found during infection by the infectious agent causing bovine spongiform encephalopathy (BSE). To investigate the molecular basis of BSE adaptation and selection, we established a model of coinfection of mice by both BSE and a sheep scrapie strain (C506M3). We now show that the PrP res features in these mice, characterized by glycoform ratios and electrophoretic mobilities, may be undistinguishable from those found in mice infected with scrapie only, including when mice were inoculated by both strains at the same time and by the same intracerebral inoculation route. Western blot analysis using different antibodies against sequences near the putative N-terminal end of PrP res also demonstrated differences in the main proteinase K cleavage sites between mice showing either the BSE or scrapie PrP res profile. These results, which may be linked to higher levels of PrP res associated with infection by scrapie, were similar following a challenge by a higher dose of the BSE agent during coinfection by both strains intracerebrally. Whereas PrP res extraction methods used allowed us to distinguish type 1 and type 2 PrP res, differing, like BSE and scrapie, by their electrophoretic mobilities, in the same brain region of some patients with Creutzfeldt-Jakob disease, analysis of in vitro mixtures of BSE and scrapie brain homogenates did not allow us to distinguish BSE and scrapie PrP res. These results suggest that the BSE agent, the origin of which remains unknown so far but which may have arisen from a sheep scrapie agent, may be hidden by a scrapie strain during attempts to identify it by molecular studies and following transmission of the disease in mice.     

A C-terminal protease-resistant prion fragment distinguishes ovine "CH1641-like" scrapie from bovine classical and L-Type BSE in ovine transgenic mice

The protease-resistant prion protein (PrP(res)) of a few natural scrapie isolates identified in sheep, reminiscent of the experimental isolate CH1641 derived from a British natural scrapie case, showed partial molecular similarities to ovine bovine spongiform encephalopathy (BSE). Recent discovery of an atypical form of BSE in cattle, L-type BSE or BASE, suggests that also this form of BSE might have been transmitted to sheep. We studied by Western blot the molecular features of PrP(res) in four "CH1641-like" natural scrapie isolates after transmission in an ovine transgenic model (TgOvPrP4), to see if "CH1641-like" isolates might be linked to L-type BSE. We found less diglycosylated PrP(res) than in classical BSE, but similar glycoform proportions and apparent molecular masses of the usual PrP(res) form (PrP(res) #1) to L-type BSE. However, the "CH1641-like" isolates differed from both L-type and classical BSE by an abundant, C-terminally cleaved PrP(res) product (PrP(res) #2) specifically recognised by a C-terminal antibody (SAF84). Differential immunoprecipitation of PrP(res) #1 and PrP(res) #2 resulted in enrichment in PrP(res) #2, and demonstrated the presence of mono- and diglycosylated PrP(res) products. PrP(res) #2 could not be obtained from several experimental scrapie sources (SSBP1, 79A, Chandler, C506M3) in TgOvPrP4 mice, but was identified in the 87V scrapie strain and, in lower and variable proportions, in 5 of 5 natural scrapie isolates with different molecular features to CH1641. PrP(res) #2 identification provides an additional method for the molecular discrimination of prion strains, and demonstrates differences between "CH1641-like" ovine scrapie and bovine L-type BSE transmitted in an ovine transgenic mouse model.     

Differential immunoreactivity of goat derived scrapie following in vitro misfolding versus mouse bioassay

The protein misfolding cyclic amplification (PMCA) assay allows for detection of prion protein misfolding activity in tissues and fluids from sheep with scrapie where it was previously undetected by conventional western blot and immunohistochemistry assays. Studies of goats with scrapie have yet to take advantage of PMCA, which could aid in discerning the risk of transmission between goats and goats to sheep. The aim of the current study was to adapt PMCA for evaluation of scrapie derived from goats. Diluted brain homogenate from scrapie-infected goats (i.e., the scrapie seed, PrP(Sc)) was subjected to PMCA using normal brain homogenate from ovinized transgenic mice (tg338) as the source of normal cellular prion protein (the substrate, PrP(C)). The assay end-point was detection of the proteinase K-resistant misfolded prion protein core (PrP(res)) by western blot. Protein misfolding activity was consistently observed in caprine brain homogenate diluted 10,000-fold after 5 PMCA rounds. Epitope mapping by western blot analyses demonstrated that PrP(res) post-PMCA was readily detected with an N-terminus anti-PrP monoclonal antibody (P4), similar to scrapie inoculum from goats. This was in contrast to limited detection of PrP(res) with P4 following mouse bioassay. The inverse was observed with a monoclonal antibody to the C-terminus (F99/97.6.1). Thus, brain homogenate prepared from uninoculated tg338 served as an appropriate substrate for serial PMCA of PrP(Sc) derived from goats. These observations suggest that concurrent PMCA and bioassay with tg338 could improve characterization of goat derived scrapie.     

Establishment of bovine prion peptide-based monoclonal antibodies for identifying bovine prion

To obtain high titer monoclonal antibodies (McAbs) which can react with mammalian prion protein (PrP), Balb/C mice were immunized with bovine (Bo) PrP peptide (BoPrP 209—228 aa) coupled to keyhole limpet hemocyanin (KLH). The hybridoma cell lines secreting monoclonal antibodies against the pep-tide were established by cell fusion and cloning. The obtained McAbs were applied to detect recombi-nant human, bovine and hamster PrP, cellular prion protein (PrP^c) in normal bovine brain and patho-genic scrapie prion protein (PrP^Sc) accumulated in the medulla oblongata of bovine spongiform en-cephalopathy(BSE)specimen with Western blot and immunohistochemical detection, respectively. The current procedure might offer a simple, feasible method to raise high titer antibodies for studying bio-logical features of PrP in mammals, as well as detection of transmissible spongiform encephalopathy (TSE) and diagnosis of BSE, in particular.     

Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro

Prion diseases or transmissible spongiform encephalopathy diseases are typically characterized by deposition of abnormally folded partially protease-resistant host-derived prion protein (PrPres), which is associated with activated glia and increased release of cytokines. This neuroinflammatory response may play a role in transmissible spongiform encephalopathy pathogenesis. We previously reported that brain homogenates from prion-infected mice induced cytokine protein release in primary astroglial and microglial cell cultures. Here we measured cytokine release by cultured glial cells to determine what factors in infected brain contributed to activation of microglia and astroglia. In assays analyzing IL-12p40 and CCL2 (MCP-1), glial cells were not stimulated in vitro by either PrPres purified from infected mouse brains or prion protein amyloid fibrils produced in vitro. However, significant glial stimulation was induced by clarified scrapie brain homogenates lacking PrPres. This stimulation was greatly reduced both by antibody to cyclophilin A (CyPA), a known mediator of inflammation in peripheral tissues, and by cyclosporine A, a CyPA inhibitor. In biochemical studies, purified truncated CyPA fragments stimulated a pattern of cytokine release by microglia and astroglia similar to that induced by scrapie-infected brain homogenates, whereas purified full-length CyPA was a poor stimulator. This requirement for CyPA truncation was not reported in previous studies of stimulation of peripheral macrophages, endothelial cell cardiomyocytes, and vascular smooth muscle cells. Therefore, truncated CyPA detected in brain following prion infection may have an important role in the activation of brain-derived primary astroglia and microglia in prion disease and perhaps other neurodegenerative or neuroinflammatory diseases.     

Subcritical Water Hydrolysis Effectively Reduces the In Vitro Seeding Activity of PrPSc but Fails to Inactivate the Infectivity of Bovine Spongiform Encephalopathy Prions

The global outbreak of bovine spongiform encephalopathy (BSE) has been attributed to the recycling of contaminated meat and bone meals (MBMs) as feed supplements. The use of MBMs has been prohibited in many countries; however, the development of a method for inactivating BSE prions could enable the efficient and safe use of these products as an organic resource. Subcritical water (SCW), which is water heated under pressure to maintain a liquid state at temperatures below the critical temperature (374°C), exhibits strong hydrolytic activity against organic compounds. In this study, we examined the residual in vitro seeding activity of protease-resistant prion protein (PrP^Sc) and the infectivity of BSE prions after SCW treatments. Spinal cord homogenates prepared from BSE-infected cows were treated with SCW at 230–280°C for 5–7.5 min and used to intracerebrally inoculate transgenic mice overexpressing bovine prion protein. Serial protein misfolding cyclic amplification (sPMCA) analysis detected no PrP^Sc in the SCW-treated homogenates, and the mice treated with these samples survived for more than 700 days without any signs of disease. However, sPMCA analyses detected PrP^Sc accumulation in the brains of all inoculated mice. Furthermore, secondary passage mice, which inoculated with brain homogenates derived from a western blotting (WB)-positive primary passage mouse, died after an average of 240 days, similar to mice inoculated with untreated BSE-infected spinal cord homogenates. The PrP^Sc accumulation and vacuolation typically observed in the brains of BSE-infected mice were confirmed in these secondary passage mice, suggesting that the BSE prions maintained their infectivity after SCW treatment. One late-onset case, as well as asymptomatic but sPMCA-positive cases, were also recognized in secondary passage mice inoculated with brain homogenates from WB-negative but sPMCA-positive primary passage mice. These results indicated that SCW-mediated hydrolysis was insufficient to eliminate the infectivity of BSE prions under the conditions tested.     

Distinct molecular phenotypes in bovine prion diseases

Bovine spongiform encephalopathy (BSE) in cattle, the most likely cause of variant Creutzfeldt–Jakob disease in humans, is thought to be caused by a unique infectious agent, with stable features, even when transmitted to other species. Here, we show the existence of an atypical molecular phenotype among cattle diagnosed with BSE in France. Following western blot analysis, three cases showed unusual features of the electrophoretic profiles of the protease-resistant prion protein (PrP^res) accumulating in the brain. The PrP^res patterns were similar in these three atypical cases, showing a higher molecular mass of unglycosylated PrP^res and strong labelling by P4 monoclonal antibody compared to 55 typical BSE cases. This finding suggests either some phenotypic modifications of PrP^res following infection by the BSE agent or the existence of alternative origins of such diseases in cattle.